In order to patent a new chemical compound, which is to be used for medical purposes, it is necessary to present already in the patent application the results of a research confirming its therapeutic effects.

In the latest issue of the magazine “The World of Pharmaceutical Industry” (“Świat Przemysłu Farmaceutycznego”) Barbara Milczarek, a patent attorney at Patpol, discussed the obligation of a sufficient disclosure of invention in the context of the application procedures.

We invite you to read the full article in polish.

Patpol awarded as the Best IP Advisor in Central and Eastern Europe!

We are delighted to inform about our latest industry recognition as the 2020 Best IP Czytaj dalej

The Polish Cheese Congress is behind us!

Thank you for participating in the Patpol and Patpol Legal lectures during the Polish Cheese Czytaj dalej

RECOMMENDATION IN THE PATENT LAWYER MAGAZINE!

We are happy to announce that we have received a recommendation in the ranking of Czytaj dalej